Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Latest Chinese Healthcare Reform Release Offers Little Change

This article was originally published in PharmAsia News

Executive Summary

According to an industry insider privy to China's healthcare reform draft soliciting the latest round of public opinion (PharmAsia News, Sep.15, 2008), the overall plan does not differ much from the previous version in terms of new concepts or changes. It seems to hammer together hodge-podge proposals from various organizations, with little specifics on execution and operation. Although the reform seeks to resolve the problem of "medical care sustained by drug income" through separate management of hospitals' income and expenses, the strategy does not address the fundamental issues. Current media only cover small portions of the entire plan as the opinion soliciting period will only be closed in about a month's time. (Click here for more - Chinese Language)

You may also be interested in...

China State Council Solicits Public Opinion Again For Healthcare Reform Plan

China's State Council has decided to solicit public opinion again to deepen its health care reform proposal. The draft spells out the reform's direction, objective, principles and key measures, with the overall goal of building up the basic healthcare system to cover both urban and rural residents by 2020. In the near term, the government will focus on five areas: (1) speeding up the guaranteed coverage of healthcare; (2) building a national basic medicine system; (3) completing health care service system at the primary level; (4) promoting uniform basic healthcare service; and (5) pushing reform pilots in public hospitals. A reform participant discloses that the proposal comprises a health reform framework and a complementary set of documents, with the latter detailing specific measures for implementation. (Click here for more - Chinese Language)

China Poised To Conditionally Approve First COVID Vaccine

The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.

Novartis Faces Another Challenge To Entresto In India

More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts